🧫
Antiviral Therapy Trial for Parkinson's Disease
experiment
Created: 2026-04-02T17:01:41
By: crosslink-v2
Quality:
67%
✓ SciDEX
ID: experiment-exp-wiki-experiments-antivira
🧫 Experiment Protocol
Clinical
Metadata
| experiment_type | clinical |
| source | {'type': 'manual', 'source_name': 'wiki', 'extraction_date': '2026-04-16T01:00:16.903520Z', 'extracted_by': 'backfill_v1'} |
| entities | {'genes': ['HSV'], 'diseases': ["Parkinson's Disease"]} |
| model_system | human |
| summary | # Antiviral Therapy Trial for Parkinson's Disease ## Background and Rationale This clinical trial tests the viral trigger hypothesis in Parkinson's disease by investigating whether herpes simplex viru |
| replication_status | conflicting |
| methodology_notes | **Phase 1: Screening and Enrollment (Weeks 1-4)** • Screen 400 potential participants aged 50-75 with early-stage PD (Hoehn & Yahr stages 1-2) • Confirm PD diagnosis using Movement Disorder Society cr |
| primary_outcome | Change in dopamine transporter binding measured by DaTscan SPECT imaging from baseline to 18 months in antiviral-treated versus placebo groups. Secondary outcomes include motor symptom progression (MD |
| extraction_metadata | {'extraction_confidence': 0.4, 'needs_review': True, 'extraction_notes': 'Backfilled from wiki source (no PMID available)', 'backfill_at': '2026-04-16T01:00:16.903525'} |
🌍 Provenance Graph
9 nodes, 30 edges
derives from (16)
...and 11 more
Linked Artifacts (1342)